Tagged with Medical

South Korea This week the Korean Ministry of Food and Drug Safety announced that as of 12th March 2019 a revised narcotics bill will go into effect that will allow imports of medical cannabis for self-treatment but under strict conditions.   Until now, the import, export, manufacturing and sale of cannabis has been…

Egypt Egypt has found a way to profit from the country’s access to cheap Hep C drugs by offering package holidays to tourists suffering from the disease, but the ‘tour and cure’ model raises numerous questions.   Egypt has a long history struggling with Hepatitis C (HCV) that started in the…

China Dr Dan Zhang, CEO of Fountain Medical Development (FMD), details the transformation China’s recent membership at the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) will bring to the drug development and clinical research landscape in China, the pressures and opportunities local companies…

Algeria Yahia Aktouf outlines the relationship between Aktouf Medical and Philips Healthcare in Algeria, the evolution of the Algerian medtech market and the potential to bring innovative products to North Africa.   The evolution [of the Algerian medtech sector] between 1997 and now has been very significant in terms of development…

Malaysia Click here to download the Healthcare & Life Sciences Review Malaysia 2018. After recent elections conducted in May 2018 saw Mahathir Mohamad returning as Prime Minister after 15 years to seal a historic victory, Malaysia is again back on its feet. Bolstered by well-established institutions, a fully-functional IP framework and strong…

Malaysia Sherene Azli, CEO of the Malaysia Healthcare Travel Council (MHTC), introduces this unique organization in charge of promoting Malaysia internationally as the ‘Cardiology and Fertility Hub of Asia’ and explains the advantages of receiving medical treatment in Malaysia.   Our main goal is to establish Malaysia as the leading global…

Turkey With the construction of state-of-the-art public and private hospitals, Turkey is poised to become a global leader in medical tourism.   Turkey has always been a popular tourist destination, given its unrivaled history and cultural appeal, and now, after years of large-scale investments by both the private and public sector,…

Cyprus With a population of just 1.2 million and a proportionately small pharmaceutical market by EU standards, Cyprus is often overlooked as a healthcare and life sciences investment destination. However, with the island now on the road to economic recovery following the EUR ten billion IMF-ECB-EU troika bailout in 2013, an…

Turkey Emin Çakmak, chairman of the Turkish Healthcare Travel Council, offers deep insights into the healthcare travel industry and how it stretches beyond the commonly used term of “medical tourism”. Çakmak also elaborates on the current dynamics of the industry in Turkey, the features that have made the country a choice…

Cyprus Cyprus is capitalizing on its well-established tourism infrastructure to stake a claim for itself as one of Europe’s premier medical tourism destinations. “I believe Cyprus can become a really important hub for medical tourism thanks to our welcoming culture, great weather and educated talent pool.” Christoforos Hadjikyprianou, CEO of European…

Cyprus Polis Peratikos of the Cyprus Health Services Promotion Board leads the operation promoting the healthcare tourism capabilities of Cyprus across the world, notably in the UK and Russia. In this interview he introduces healthcare villages, their scope of operations, and why the time to invest in Cyprus is now. Could…

Hong Kong Professor Justin Wu, chief operating officer of the Chinese University of Hong Kong (CUHK) Medical Center, shares his professional background and interest in gastroenterology, his insights into the research and commercialization environment in Hong Kong, and his hope for government, industry and academia to work together to propel Hong Kong…